rector of the Agency for Healthcare Research and Quality, 
shall carry out surveillance activities to collect population- 
wide data on cannabis use. 
‘‘(b) PERMISSIBLE ACTIVITIES.— 
‘‘(1) IN GENERAL.—In carrying out activities 
under this section, the Secretary may collect, as ap-
propriate, with respect to cannabis use— 
‘‘(A) data on— 
‘‘(i) health outcomes, including bio-
logical data; 
‘‘(ii) health care utilization, which 
shall include hospitalizations and utiliza-
tion of emergency departments related to 
consumption of cannabis, including among 
youth; 
‘‘(iii) demographic factors associated 
with cannabis use; 
‘‘(iv) the variety of products and deliv-
ery modes used; and 
‘‘(v) other relevant health information 
to improve the understanding of cannabis 
use in all age groups and sub-populations; 
and 
‘‘(B) data through public health surveil-
lance systems, surveys, questionnaires, and 
VerDate Sep 11 2014 
23:16 Sep 13, 2019
Jkt 089200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H4322.IH
H4322
kjohnson on DSK79L0C42 with BILLS
databases of health care records, including, as 
appropriate, the Behavioral Risk Factor Sur-
veillance System, the Youth Risk Behavioral 
Surveillance System, the Monitoring the Future 
health survey, the National Survey on Drug 
Use and Health, or the Healthcare Cost and 
Utilization Project (or any successor surveys). 
‘‘(2) PRIVACY.—Any data collected under para-
graph (1) shall be collected in manner that protects 
personal privacy to the extent, at a minimum, that 
is required under applicable Federal and State 
law.’’. 
SEC. 3. RESCHEDULING OF MARIHUANA. 
(a) IN GENERAL.—Subsection (c) of schedule I of 
section 202(c) of the Controlled Substances Act (21 
U.S.C. 812(c)) is amended by striking paragraph (10). 
(b) SCHEDULE III.—Schedule III of section 202(c) 
of the Controlled Substances Act (21 U.S.C. 812(c)) is 
amended by adding at the end the following: 
‘‘(f) Marihuana.’’. 
SEC. 4. CENTERS OF EXCELLENCE IN CANNABIS RE-
SEARCH. 
(a) IN GENERAL.—Part B of title IV of the Public 
Health Service Act (42 U.S.C. 284 et seq.), as amended 
VerDate Sep 11 2014 
23:16 Sep 13, 2019
Jkt 089200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H4322.IH
H4322
kjohnson on DSK79L0C42 with BILLS
by section 2(a), is further amended by adding at the end 
the following: 
‘‘SEC. 409L. CENTERS OF EXCELLENCE IN CANNABIS RE-
SEARCH. 
‘‘(a) DESIGNATION.— 
‘‘(1) IN GENERAL.—The Director of NIH shall 
designate institutions of higher education as Centers 
of Excellence in Cannabis Research for the purpose 
of interdisciplinary research related to cannabis and 
other biomedical, behavioral, and social issues re-
lated to cannabis. No institution of higher education 
may be designated as a Center unless an application 
therefor has been submitted to, and approved by, the 
Director of NIH. Such an application shall be sub-
mitted in such manner and contain such information 
as the Director of NIH may reasonably require. The 
Director of NIH may not approve such an applica-
tion unless— 
‘‘(A) the application contains or is sup-
ported by reasonable assurances that— 
‘‘(i) at least 1 individual employed by 
the applicant— 
‘‘(I) is registered under section 
303(f) of the Controlled Substances 
Act to conduct research with con-
VerDate Sep 11 2014 
23:16 Sep 13, 2019
Jkt 089200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H4322.IH
H4322
kjohnson on DSK79L0C42 with BILLS
trolled substances in schedule III of 
section 202(c) of that Act; and 
‘‘(II) is an active participant in 
the cannabis research activities of the 
applicant; 
‘‘(ii) the applicant has not had a reg-
istration to conduct research with con-
trolled substances under section 303 of the 
Controlled Substances Act denied, revoked, 
or suspended under section 304 of that 
Act; 
‘‘(iii) the applicant has the experience, 
or capability, to conduct, through bio-
medical, behavioral, social, and related dis-
ciplines, long-term research on cannabis 
and to provide coordination of such re-
search among such disciplines; 
‘‘(iv) the applicant has available to it 
sufficient personnel and facilities (includ-
ing laboratory, reference, storage, security, 
and data analysis facilities) to carry out 
the research plan required under subpara-
graph (B); and 
‘‘(v) the applicant has the capacity to 
conduct academic courses and train stu-
VerDate Sep 11 2014 
23:16 Sep 13, 2019
Jkt 089200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H4322.IH
H4322
kjohnson on DSK79L0C42 with BILLS
dents and professionals on appropriate re-
search and knowledge of cannabis; and 
‘‘(B) the application contains a detailed 5- 
year plan for research relating to cannabis. 
‘‘(2) GEOGRAPHIC REPRESENTATION.—The Di-
rector of NIH shall ensure geographic representation 
across the United States in designating institutions 
of higher education as Centers of Excellence in Can-
nabis Research. 
‘‘(3) TERM
OF
DESIGNATION.—A designation 
under this section shall be for a period of 5 years. 
An institution of higher education may reapply in 
accordance with the requirements under paragraph 
(1) for a subsequent designation under this section. 
‘‘(b) CANNABIS RESEARCH.— 
‘‘(1) 
GRANTS
OR
COOPERATIVE
AGREE-
MENTS.— 
‘‘(A) IN GENERAL.—The Director of NIH 
may make grants to, or enter into cooperative 
agreements with, Centers that have been des-
ignated under this section to expand the cur-
rent and ongoing interdisciplinary research and 
clinical trials relating to cannabis research. 
‘‘(B) USE
OF
FUNDS.—Amounts made 
available under a grant or cooperative agree-
VerDate Sep 11 2014 
23:16 Sep 13, 2019
Jkt 089200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H4322.IH
H4322
kjohnson on DSK79L0C42 with BILLS